Wednesday, July 8, 2026

Drug profile · INN

sodium succinate

sodium succinate (SODIUM SUCCINATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 7
News articles 0
Drug details — sodium succinate
US status
approved
Class
Route
INJECTION
Patents
0
Programs
7
Data quality
0.84

Quick answer

sodium succinate (SODIUM SUCCINATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN sodium succinate
Brand SODIUM SUCCINATE
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. ALL2820 Phase 3 · Telethon Foundation · Adult Philadelphia Chromosome-Positive Acute Lymphoblastic L
  2. Methylprednisolone sodium succinate Phase 3 · First People's Hospital · Acute Ischemic Stroke
  3. The methylprednisolone sodium succinate Phase 3 · First People's Hospital · Acute Ischemic Stroke
  4. WA40404 Phase 3 · HOFFMANN-LA ROCHE · Primary progressive multiple sclerosis (PPMS)
  5. ALL3024 Phase 2 · Telethon Foundation · Very High-Risk T-Lineage Acute Lymphoblastic Leukemia (ALL)
  6. GIMEMA ALL2922 Phase 2 · Telethon Foundation · Adult Philadelphia Chromosome-Negative Acute Lymphoblastic L
  7. RP-A501-0123 Phase 2 · Anaxis Pharma · Danon Disease

Frequently asked questions

What is sodium succinate?

sodium succinate (SODIUM SUCCINATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for sodium succinate?

SODIUM SUCCINATE is a marketed brand name for sodium succinate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sodium succinate?

sodium succinate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.